Literature DB >> 26069059

Clinical Chemistry and Other Laboratory Tests on Mouse Plasma or Serum.

Birgit Rathkolb1,2, Wolfgang Hans1, Cornelia Prehn1, Helmut Fuchs1, Valérie Gailus-Durner1, Bernhard Aigner2, Jerzy Adamski1,3, Eckhard Wolf2, Martin Hrabě de Angelis1,3,4.   

Abstract

Besides hematological analyses, many other parameters, including clinical chemistry and endocrinological values, can be determined from mouse blood samples. For most of these tests, plasma or serum samples are used. Data obtained by these investigations provide indications of genotype effects on metabolism and organ functions. Here we describe in detail the considerations that have to be taken into account to get adequate samples for plasma or serum analyses and the recommended sample processing for different investigations. Furthermore, we describe established methods used in the German Mouse Clinic (GMC) to determine clinical chemical parameters; for more in-depth analysis of specific classes of biomarkers, we provide instructions for ELISAs (sandwich and competitive) as well as LC-MS/MS, focusing on markers associated with bone or steroid metabolism in the mouse as working examples. Curr. Protoc. Mouse Biol. 3:69-100 © 2013 by John Wiley & Sons, Inc.
Copyright © 2013 John Wiley & Sons, Inc.

Entities:  

Keywords:  ELISA; PINP; clinical chemistry; mass spectrometry; mouse; osteocalcin; steroids

Year:  2013        PMID: 26069059     DOI: 10.1002/9780470942390.mo130043

Source DB:  PubMed          Journal:  Curr Protoc Mouse Biol        ISSN: 2161-2617


  19 in total

1.  No amelioration of uromodulin maturation and trafficking defect by sodium 4-phenylbutyrate in vivo: studies in mouse models of uromodulin-associated kidney disease.

Authors:  Elisabeth Kemter; Stefanie Sklenak; Birgit Rathkolb; Martin Hrabě de Angelis; Eckhard Wolf; Bernhard Aigner; Ruediger Wanke
Journal:  J Biol Chem       Date:  2014-02-24       Impact factor: 5.157

2.  A novel biological function of soluble biglycan: Induction of erythropoietin production and polycythemia.

Authors:  Helena Frey; Kristin Moreth; Louise Tzung-Harn Hsieh; Jinyang Zeng-Brouwers; Birgit Rathkolb; Helmut Fuchs; Valérie Gailus-Durner; Renato V Iozzo; Martin Hrabě de Angelis; Liliana Schaefer
Journal:  Glycoconj J       Date:  2016-09-06       Impact factor: 2.916

3.  Fgf9 Y162C Mutation Alters Information Processing and Social Memory in Mice.

Authors:  Lillian Garrett; Lore Becker; Jan Rozman; Oliver Puk; Tobias Stoeger; Ali Önder Yildirim; Alexander Bohla; Oliver Eickelberg; Wolfgang Hans; Cornelia Prehn; Jerzy Adamski; Thomas Klopstock; Ildikó Rácz; Andreas Zimmer; Martin Klingenspor; Helmut Fuchs; Valerie Gailus-Durner; Wolfgang Wurst; Martin Hrabě de Angelis; Jochen Graw; Sabine M Hölter
Journal:  Mol Neurobiol       Date:  2017-07-10       Impact factor: 5.590

4.  A protocol for evaluation of Rett Syndrome symptom improvement by metabolic modulators in Mecp2-mutant mice.

Authors:  Christie M Buchovecky; Misty G Hill; Jennifer M Borkey; Stephanie M Kyle; Monica J Justice
Journal:  Curr Protoc Mouse Biol       Date:  2013

5.  Serum Response Factor (SRF) Ablation Interferes with Acute Stress-Associated Immediate and Long-Term Coping Mechanisms.

Authors:  Annemarie Zimprich; Gabi Mroz; Christopher Meyer Zu Reckendorf; Sofia Anastasiadou; Philip Förstner; Lillian Garrett; Sabine M Hölter; Lore Becker; Jan Rozman; Cornelia Prehn; Birgit Rathkolb; Kristin Moreth; Wolfgang Wurst; Thomas Klopstock; Martin Klingenspor; Jerzy Adamski; Eckhard Wolf; Raffi Bekeredjian; Helmut Fuchs; Valerie Gailus-Durner; Martin Hrabe de Angelis; Bernd Knöll
Journal:  Mol Neurobiol       Date:  2016-12-02       Impact factor: 5.590

6.  Clinical Chemistry Reference Intervals for C57BL/6J, C57BL/6N, and C3HeB/FeJ Mice (Mus musculus).

Authors:  Gordon P Otto; Birgit Rathkolb; Manuela A Oestereicher; Christoph J Lengger; Corinna Moerth; Kateryna Micklich; Helmut Fuchs; Valérie Gailus-Durner; Eckhard Wolf; Martin Hrabě de Angelis
Journal:  J Am Assoc Lab Anim Sci       Date:  2016       Impact factor: 1.232

7.  Oxalate-induced chronic kidney disease with its uremic and cardiovascular complications in C57BL/6 mice.

Authors:  Shrikant R Mulay; Jonathan N Eberhard; Victoria Pfann; Julian A Marschner; Murthy N Darisipudi; Christoph Daniel; Simone Romoli; Jyaysi Desai; Melissa Grigorescu; Santhosh V Kumar; Birgit Rathkolb; Eckhard Wolf; Martin Hrabě de Angelis; Tobias Bäuerle; Barbara Dietel; Carsten A Wagner; Kerstin Amann; Kai-Uwe Eckardt; Peter S Aronson; Hans Joachim Anders; Felix Knauf
Journal:  Am J Physiol Renal Physiol       Date:  2016-01-13

8.  Analogs of penfluridol as chemotherapeutic agents with reduced central nervous system activity.

Authors:  Md Ashraf-Uz-Zaman; Md Sanaullah Sajib; Luca Cucullo; Constantinos M Mikelis; Nadezhda A German
Journal:  Bioorg Med Chem Lett       Date:  2018-10-24       Impact factor: 2.823

9.  Pleiotropic functions for transcription factor zscan10.

Authors:  Petra Kraus; Sivakamasundari V; Hong Bing Yu; Xing Xing; Siew Lan Lim; Thure Adler; Juan Antonio Aguilar Pimentel; Lore Becker; Alexander Bohla; Lillian Garrett; Wolfgang Hans; Sabine M Hölter; Eva Janas; Kristin Moreth; Cornelia Prehn; Oliver Puk; Birgit Rathkolb; Jan Rozman; Jerzy Adamski; Raffi Bekeredjian; Dirk H Busch; Jochen Graw; Martin Klingenspor; Thomas Klopstock; Frauke Neff; Markus Ollert; Tobias Stoeger; Ali Önder Yildrim; Oliver Eickelberg; Eckhard Wolf; Wolfgang Wurst; Helmut Fuchs; Valérie Gailus-Durner; Martin Hrabě de Angelis; Thomas Lufkin; Lawrence W Stanton
Journal:  PLoS One       Date:  2014-08-11       Impact factor: 3.240

10.  Meis1: effects on motor phenotypes and the sensorimotor system in mice.

Authors:  Aaro V Salminen; Lillian Garrett; Barbara Schormair; Jan Rozman; Florian Giesert; Kristina M Niedermeier; Lore Becker; Birgit Rathkolb; Ildikó Rácz; Martin Klingenspor; Thomas Klopstock; Eckhard Wolf; Andreas Zimmer; Valérie Gailus-Durner; Miguel Torres; Helmut Fuchs; Martin Hrabě de Angelis; Wolfgang Wurst; Sabine M Hölter; Juliane Winkelmann
Journal:  Dis Model Mech       Date:  2017-06-23       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.